Details for New Drug Application (NDA): 214525
✉ Email this page to a colleague
The generic ingredient in MYCOPHENOLATE MOFETIL is mycophenolate mofetil hydrochloride. There are thirty-eight drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the mycophenolate mofetil hydrochloride profile page.
Summary for 214525
Tradename: | MYCOPHENOLATE MOFETIL |
Applicant: | Lannett Co Inc |
Ingredient: | mycophenolate mofetil |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 214525
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MYCOPHENOLATE MOFETIL | mycophenolate mofetil | FOR SUSPENSION;ORAL | 214525 | ANDA | Lannett Company, Inc. | 0527-5160 | 0527-5160-82 | 1 BOTTLE, PLASTIC in 1 CARTON (0527-5160-82) / 225 mL in 1 BOTTLE, PLASTIC |
MYCOPHENOLATE MOFETIL | mycophenolate mofetil | FOR SUSPENSION;ORAL | 214525 | ANDA | NorthStar RxLLC | 16714-345 | 16714-345-01 | 1 BOTTLE, PLASTIC in 1 CARTON (16714-345-01) / 225 mL in 1 BOTTLE, PLASTIC |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SUSPENSION;ORAL | Strength | 200MG/ML | ||||
Approval Date: | Jul 29, 2021 | TE: | AB | RLD: | No |
Complete Access Available with Subscription